Capital Advantage, Inc. Abbott Laboratories Transaction History

Capital Advantage, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $462,408 - $544,320	-4,371 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $1,959 - $2,308	18 Added 0.41%	4,371 $524,000
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $27,300 - $29,749	260 Added 6.35%	4,353 $481,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $375,082 - $455,509	4,093 New	4,093 $441,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $331,394 - $424,144	-4,328 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $125 - $183	-2 Reduced 0.05%	4,328 $416,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $26,222 - $29,191	334 Added 8.36%	4,330 $391,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $327,032 - $354,605	3,996 New	3,996 $334,000
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $205,613 - $248,586	-3,105 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $2,163 - $2,450	-33 Reduced 1.05%	3,105 $225,000
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $190,821 - $230,203	3,138 New	3,138 $230,000

3,167

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital Advantage, Inc. with notifications on news.